Prof. Dr. med. Georg Schett



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Accuracy and usability of a diagnostic decision support system in the diagnosis of three representative rheumatic diseases: a randomized controlled trial among medical students (2021) Knitza J, Tascilar K, Gruber E, Kaletta H, Hagen M, Liphardt AM, Schenker H, et al. Journal article Systemic versus local adipokine expression differs in a combined obesity and osteoarthritis mouse model (2021) Hülser ML, Luo Y, Frommer K, Hasseli R, Köhler K, Diller M, Van Nie L, et al. Journal article TGFβ promotes fibrosis by MYST1-dependent epigenetic regulation of autophagy (2021) Zehender A, Li YN, Lin NY, Stefanica A, Nüchel J, Chen CW, Hsu HH, et al. Journal article Does methotrexate influence COVID-19 infection? Case series and mechanistic data (2021) Schaelter F, Dürholz K, Bucci L, Burmester G, Caporali R, Figuereido C, Cobra JF, et al. Journal article Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trial (2021) Knitza J, Mohn J, Bergmann C, Kampylafka E, Hagen M, Bohr D, Morf H, et al. Journal article Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs (2021) Vodencarevic A, Tascilar K, Reiser M, Hueber A, Haschka J, Bayat S, Meinderink T, et al. Journal article Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis (2021) Valor-Méndez L, Kleyer A, Rech J, Manger B, Schett G Journal article Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections (2021) Bénard A, Jacobsen A, Brunner M, Krautz C, Klösch B, Swierzy I, Naschberger E, et al. Journal article Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS) (2021) Coates LC, Gossec L, Theander E, Bergmans P, Neuhold M, Karyekar CS, Shawi M, et al. Journal article Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA (2021) Martinsson K, Dürholz K, Schett G, Zaiss M, Kastbom A Journal article